Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The eClinical solutions market is forecasted to grow at a CAGR of 12.1 % to reach USD 7.61 billion by the end of 2022. Owing to the large population and thus patient pools, countries like India and China are hosting many clinical trials; Government spending in clinical research has also fueled the need for the product. Increased outsourcing of clinical trials to contract research organizations along with alliances collaborations and acquisition for the development of clinical research further provides huge scope for new entrants in the market. Increased operational costs associated with clinical research studies is another major driving factor for this market. However, concerns over lack of skilled research professionals, lack of awareness of infrastructure in developing countries and patient data privacy could be impediments to its growth.
Market Segmentation
Based on product, it can be segmented into Electronic Data Capture and Client Data Management Systems, Clinical trial management systems, Clinical Analytics Platform, Randomization and Trial Management Systems, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment, Electronic Trial Master Files, Regulatory Information Management Systems and Safety Solutions. Based on delivery mode, it can be segmented into Web hosted or On demand, License enterprise or On premise and Cloud based or SaaS. By clinical trial phase, it can be segmented into Phase I to IV. Finally, on end users, it can be segmented into Pharmaceutical and Biopharmaceutical companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals and Academic Research institutions.
Geographic Analysis
Emerging markets like China, Taiwan, South Korea and China are the most attractive markets for eClinical Solutions due to presence of low operating costs. Less stringent regulatory guidelines and growth of life science research are key factors for pushing the need in these emerging markets. North America was however the largest segment as of now followed by Europe. The large market in North America is due to the huge number of trials ongoing in the region. However, Asia Pacific recorded the highest CAGR.
Key Players
Some of the key players in the Industry are Oracle Corporation, PHT Corporation, Parexel International Corporation, Bio-Optronics Inc., Medidata Solution, Inc., MaxisIT Inc., BioClinica, OmniComm Systems Inc., DataTrak International, Inc., eClinical Solutions, CRF Health, ERT and Merge Health Incorporated.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...